Skip to main content

Beneficial ownership — 13D / 13G

87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Berkshire Hathaway Inc CVX Chevron Corp 13G/A 6.7% 2y
Sculptor Capital LP RCAC Revelstone Capital Acquisition Corp. Class A Common Stock 13G/A 0% 2y
Berkshire Hathaway Inc HPQ Hp Inc 13G/A 2.3% 2y
Anson Funds Management LP XXII 22nd Century Group, Inc. 13G 7.3% 2y
PERCEPTIVE ADVISORS LLC CRGX CARGO Therapeutics, Inc. Common Stock 13G/A 8.3% 2y
Greenhouse Funds LLLP CHEF Chefs' Warehouse, Inc. 13G/A 5.9% 2y
TIGER GLOBAL MANAGEMENT LLC RERE ATRenew Inc. 13G/A 8.4% 2y
GENERATION INVESTMENT MANAGEMENT LLP JLL Jones Lang Lasalle Inc 13G/A 8.84% 2y
RPD Fund Management LLC RMAX RE/MAX Holdings, Inc. 13G/A 6% 2y
VERIZON COMMUNICATIONS INC BZFD BuzzFeed, Inc. 13G/A 8.3% 2y
Sandia Investment Management LP DMYY dMY Squared Technology Group, Inc. 13G/A 7.9% 2y
Ming Yan CTKB Cytek Biosciences, Inc. 13G/A 4.7% 2y
Radcliffe Capital Management, L.P. GACQ Global Consumer Acquisition Corp. Common Stock 13G/A 0% 2y
ALLIANCEBERNSTEIN L.P. CTRN Citi Trends Inc 13G/A 10.7% 2y
Fourthstone LLC SLBK Skyline Bankshares, Inc. 13G 9.84% 2y
ARMISTICE CAPITAL, LLC LGVN Longeveron Inc. 13G 7.31% 2y
TANG CAPITAL MANAGEMENT, LLC IFRX InflaRx N.V. 13G/A 3.2% 2y
Everbright International Development Limited SFWL SHENGFENG DEVELOPMENT Ltd 13G 21.5% 2y
ARMISTICE CAPITAL, LLC MYSZ My Size, Inc. 13G 9.99% 2y
Fund 1 Investments, LLC VNCE Vince Holding Corp. 13G/A 9.94% 2y
T. Rowe Price Investment Management, Inc. CWT California Water Service Group 13G 5% 2y
PRICE T ROWE ASSOCIATES INC /MD/ ELV Elevance Health, Inc. 13G 5.1% 2y
22NW Fund, LP MACK Merrimack Pharmaceuticals, Inc. 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. PZZA Papa Johns International Inc 13G/A 11.5% 2y
Joe Kiani MASI Masimo Corp 13G/A 9.2% 2y
PRICE T ROWE ASSOCIATES INC /MD/ SLB Slb Limited 13G 5.3% 2y
EAGLE CAPITAL MANAGEMENT LLC WWD Woodward, Inc. 13G/A 6.54% 2y
Deep Track Capital, LP ATXS Astria Therapeutics, Inc. Common Stock 13G/A 0% 2y
WHITEBOX ADVISORS LLC GPGI GPGI, Inc. 13G/A 9.9% 2y
Global X Management CO LLC AEGXF Aecon Group Inc. 13G 5.46% 2y
Orbis Investment Management Limited VAL Valaris Ltd 13G 7.9% 2y
RA CAPITAL MANAGEMENT, L.P. TRML Tourmaline Bio, Inc. Common Stock 13G/A 0% 2y
PRICE T ROWE ASSOCIATES INC /MD/ TDW Tidewater Inc 13G/A 9.8% 2y
TMT General Partner Ltd SOGP Sound Group Inc. 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. CNDT CONDUENT Inc 13G 5% 2y
BESSEMER GROUP INC BAB Invesco Exchange-Traded Fund Trust II 13G 5.07% 2y
Sculptor Capital LP SDRL SEADRILL Ltd 13G/A 3.47% 2y
AQR CAPITAL MANAGEMENT LLC SKGR SK Growth Opportunities Corporation Class A Common Stock 13G 9.94% 2y
ARMISTICE CAPITAL, LLC MTRI InMed Pharmaceuticals Inc. 13G/A 9.99% 2y
CADIAN CAPITAL MANAGEMENT, LP TCMD Tactile Systems Technology Inc 13G 7.4% 2y
ARMISTICE CAPITAL, LLC TOPS Top Ships Inc. 13G/A 4.99% 2y
T. Rowe Price Investment Management, Inc. PFBC Preferred Bank 13G/A 6.4% 2y
First Trust Capital Management L.P. ISRLF Israel Acquisitions Corp 13G 6.36% 2y
Joel Bender WHD Cactus, Inc. 13G/A 16% 2y
ARISTEIA CAPITAL, L.L.C. TRTL TortoiseEcofin Acquisition Corp. III 13G/A 5.79% 2y
Rock Springs Capital Management LP AGIO Agios Pharmaceuticals, Inc. 13G/A 3.85% 2y
PRICE T ROWE ASSOCIATES INC /MD/ DSGX Descartes Systems Group Inc 13G/A 8.6% 2y
D1 Capital Partners L.P. RH Rh 13G/A 1.8% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC BRW Saba Capital Income & Opportunities Fund 13G/A 7.25% 2y
ARMISTICE CAPITAL, LLC HEPA Hepion Pharmaceuticals, Inc. 13G 8.67% 2y